Tumor immunity: a novel dimension for PROTACs to conquer cancer?

Affiliations

• ¹ Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
• ² The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, 310058, China. pharmacy_zwb@zju.edu.cn.
• ³ Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. zhanzhou@zju.edu.cn.
• ⁴ The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, 310058, China. zhanzhou@zju.edu.cn.
• ⁵ Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. zhanzhou@zju.edu.cn.
• ⁶ Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. caoji88@zju.edu.cn.
• ⁷ The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, 310058, China. caoji88@zju.edu.cn.
• ⁸ Cancer Center of Zhejiang University, Hangzhou, 310058, China. caoji88@zju.edu.cn.